孕早期血生化指标预测妊娠期糖尿病的研究进展
Research Progress on Blood Biochemical In-dexes in the First Trimester of Pregnancy in Predicting Gestational Diabetes
DOI: 10.12677/ACM.2024.141270, PDF,   
作者: 宋玉洁, 朱启英*：新疆医科大学第一附属医院，新疆 乌鲁木齐
关键词: 妊娠期糖尿病；血生化指标；早期预测；Gestational Diabetes Mellitus； Blood Biochemical Parameters； Early Prediction
摘要: 妊娠期糖尿病(GDM)的发病率高，且对母儿近期及远期健康均可造成不良影响。因此，早期发现GDM高危孕妇，尽早进行临床干预，对改善母婴预后至关重要。目前研究发现，多种血生化指标在孕早期与GDM的发生风险增加有关，包括糖类指标、血脂指标、脂肪因子、炎症因子等。本文对孕早期血生化指标预测GDM的研究进展进行综述，为建立合理的GDM孕早期预测模型提供依据。
Abstract: Gestational diabetes mellitus (GDM) has a high incidence and can adversely affect the health of both mother and child in the near and long term. Therefore, early detection of pregnant women at high risk of GDM and early clinical intervention are crucial to improve maternal and infant prognosis. At present, studies have found that a variety of blood biochemical indicators are associated with an in-creased risk of GDM in the first trimester, including carbohydrate indexes, blood lipid indicators, adipokines, inflammatory factors, etc. This article reviews the research progress of blood biochemi-cal indicators in the first trimester of pregnancy in predicting GDM, so as to provide a basis for the establishment of a reasonable prediction model of GDM in the first trimester.
文章引用：宋玉洁, 朱启英. 孕早期血生化指标预测妊娠期糖尿病的研究进展[J]. 临床医学进展, 2024, 14(1): 1915-1921. https://doi.org/10.12677/ACM.2024.141270

参考文献

[1] American Diabetes Association (2018) Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabe-tes-2018. Diabetes Care, 41, S13-S27. [Google Scholar] [CrossRef] 
[2] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华糖尿病杂志, 2021, 13(4): 315-409.
[3] 颜廷媛, 陈雅暖, 徐金娥, 等. 妊娠期糖尿病与妊娠期高血压疾病相关性研究进展[J]. 精准医学杂志, 2023, 38(3): 279-282.
[4] Orazmuradov, A., Bekbaeva, I., Arakelyan, G., et al. (2023) Complications of the Early Neonatal Period in Children from Mothers with Gestational Diabetes Mellitus. International Journal of Biomedicine, 11, 414-417. [Google Scholar] [CrossRef] 
[5] 中华医学会妇产科学分会产科学组, 中华医学会围产医学分会, 中国妇幼保健协会妊娠合并糖尿病专业委员会. 妊娠期高血糖诊治指南(2022) [第一部分] [J]. 中华妇产科杂志, 2022, 57(1): 3-12.
[6] WHO Guidelines Approved by the Guidelines Review Committee (2023) Diagnostic Cri-teria and Classification of Hyperglycaemia First Detected in Pregnancy. World Health Organization, Gene-va.
[7] Kansu-Celik, H., Ozgu-Erdinc, A.S., Kisa, B., et al. (2019) Maternal Serum Glycosylated Hemoglobin and Fasting Plasma Glucose Predicts Gestational Diabetes at the First Trimester in Turkish Women with a Low-Risk Preg-nancy and Its Relationship with Fetal Birth Weight; A Retrospective Cohort Study. Journal of Maternal-Fetal and Neo-natal Medicine, 34, 1970-1977.
[8] Tong, J.N., Wu, L.L., Chen, Y.X., et al. (2022) Fasting Plasma Glucose in the First Trimester Is Related to Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes. Endocrine, 75, 70-81. [Google Scholar] [CrossRef] [PubMed]
[9] Tundidor, D., Meek, C.L., Yamamoto, J., et al. (2021) Contin-uous Glucose Monitoring Time-in-Range and HbA1c Targets in Pregnant Women with Type 1 Diabetes. Diabetes Technology & Therapeutics, 23, 710-714. [Google Scholar] [CrossRef] [PubMed]
[10] Muhuza, M.P.U., Zhang, L., Wu, Q., et al. (2023) The Association between Maternal HbA1c and Adverse Outcomes in Gestational Diabetes. Frontiers in Endocrinology, 14, Article 1105899. [Google Scholar] [CrossRef] [PubMed]
[11] Yin, B., Hu, L., Meng, X., et al. (2021) Association of Higher HbA1c within the Normal Range with Adverse Pregnancy Outcomes: A Cross-Sectional Study. Acta Diabeto-logica, 58, 1081-1089. [Google Scholar] [CrossRef] [PubMed]
[12] 胥华猛, 张金花, 姚建荣, 等. 妊娠期糖尿病孕妇产后血糖异常影响因素及HbA1c、FPG预测价值[J]. 中国计划生育学杂志, 2022, 30(5): 1040-1044.
[13] Sun, J., Chai, S., Zhao, X., et al. (2021) Predictive Value of First-Trimester Glycosylated Hemoglobin Levels in Gestational Diabetes Mellitus: A Chinese Population Cohort Study. Journal of Diabetes Research, 2021, Article ID: 5537110. [Google Scholar] [CrossRef] [PubMed]
[14] 李楠, 周丽. 早孕期空腹血糖和三酰甘油水平对妊娠糖尿病的预测价值[J]. 医学临床研究, 2019, 36(3): 570-572.
[15] 孙静, 王健, 宋晓颖, 等. 妊娠前甘油三酯水平与妊娠期糖尿病发病相关性的研究[J]. 中国糖尿病杂志, 2021, 29(8): 584-587.
[16] 楼公先, 楼时先, 程秒鸳, 等. 孕早期FBG、HbA1c、TC、TG联合检测在妊娠期糖尿病诊断中的应用价值分析[J]. 中华全科医学, 2019, 17(5): 809-812.
[17] 孔玉玲, 石国素, 郑莉霞, 等. 联合检测孕早期血脂指标、尿糖水平对妊娠期糖尿病及妊娠结局的预测价值研究[J]. 中国实验诊断学, 2021, 25(5): 713-715.
[18] Zhu, H., He, D., Liang, N., et al. (2020) High Serum Triglyceride Levels in the Early First Trimester of Pregnancy Are Associated with Gestational Diabetes Mellitus: A Pro-spective Cohort Study. Journal of Diabetes Investigation, 11, 1635-1642. [Google Scholar] [CrossRef] [PubMed]
[19] Hu, M., Gu, X., Niu, Y., et al. (2022) Elevated Serum Triglyceride Levels at First Prenatal Visit Is Associated with the Development of Gestational Diabetes Mellitus. Diabetes/Metabolism Research and Reviews, 38, e3491. [Google Scholar] [CrossRef] [PubMed]
[20] Song, T., Su, G., Chi, Y., et al. (2022) Triglyceride-Glucose Index Pre-Dicts the Risk of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. Gynecological Endocri-nology, 38, 10-15. [Google Scholar] [CrossRef] [PubMed]
[21] Kim, J.A., Kim, J., Roh, E., et al. (2021) Triglyceride and Glucose In-Dex and the Risk of Gestational Diabetes Mellitus: A Nation-Wide Population-Based Cohort Study. Diabetes Research and Clinical Practice, 171, Article ID: 108533. [Google Scholar] [CrossRef] [PubMed]
[22] Liu, P., Liu, Y., Ma, L., et al. (2020) The Predictive Ability of Two Triglyceride-Associated Indices for Gestational Diabetes Mel-Litus and Large for Gestational Age Infant among Chinese Pregnancies: A Preliminary Cohort Study. Diabetes, Metabolic Syndrome and Obesity, 13, 2025-2035. [Google Scholar] [CrossRef] 
[23] Bellos, I., Fitrou, G., Pergialiotis, V., et al. (2019) Serum Levels of Adipokines in Gestational Diabetes: A Systematic Review. Journal of Endocrinological Investigation, 42, 621-631. [Google Scholar] [CrossRef] [PubMed]
[24] Fasshauer, M., Blü-her, M. and Stumvoll, M. (2014) Adipokines in Gestational Diabetes. The Lancet Diabetes and Endocrinology, 2, 488-499. [Google Scholar] [CrossRef] 
[25] Francisco, V., Ruiz-Fernández, C., Pino, J., et al. (2019) Adipokines: Linking Metabolic Syndrome, the Immune System, and Arthritic Diseases. Biochemical Pharmacol-ogy, 165, 196-206. [Google Scholar] [CrossRef] [PubMed]
[26] Williams, M.A., Qiu, C., Muy-Rivera, M., et al. (2004) Plasma Adiponectin Concentrations in Early Pregnancy and Subsequent Risk of Gestational Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism, 89, 2306-2311. [Google Scholar] [CrossRef] [PubMed]
[27] Madhu, S.V., Bhardwaj, S., Jhamb, R., et al. (2019) Prediction of Gestational Diabetes from First Trimester Serum Adiponectin Levels in Indian Women. Indian Journal of Endocrinology and Metabolism, 23, 536-539. [Google Scholar] [CrossRef] 
[28] Katsika, N., Mikhailidis, D.P. and Banach, M. (2018) Lcptin, Car-diovascular Discases and Type 2 Diabetes Mellitus. Acta Pharmacologica Sinica, 39, 1176-1188. [Google Scholar] [CrossRef] [PubMed]
[29] Bawah, A.T., Seini, M.M., Abaka-Yawason, A., et al. (2019) Leptin, Re-sistin and Visfatin as Useful Predictors of Gestational Diabetes Mellitus. Lipids in Health and Disease, 18, Article No. 221. [Google Scholar] [CrossRef] [PubMed]
[30] Thagaard, I.N., Krebs, L., Holm, J.C., et al. (2017) Adiponectin and Leptin as First Trimester Markers for Gestational Diabetes Mellitus: A Cohort Study. Clinical Chemistry and Labor-atory Medicine, 55, 1805-1812. [Google Scholar] [CrossRef] [PubMed]
[31] Radzicka, S., Pietryga, M., Iciek, R. and Brązert, J. (2018) The Role of Visfatin in Pathogenesis of Gestational Diabetes (GDM). Ginekologia Polska, 89, 518-521. [Google Scholar] [CrossRef] 
[32] Zhang, W.X., Zhao, D., Meng, Z.X., et al. (2018) Association be-tween Circulating Visfatin and Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. Acta Diabeto-logica, 55, 1113-1120. [Google Scholar] [CrossRef] [PubMed]
[33] Drewlo, S., Johnson, E., Kilburn, B.A., et al. (2020) Irisin Induc-es Trophoblast Differentiation via AMPK Activation in the Human Placenta. Journal of Cellular Physiology, 235, 7146-7158. [Google Scholar] [CrossRef] [PubMed]
[34] Wang, P., Ma, H.H., Hou, X.Z., et al. (2018) Reduced Plasma Level of Irisin in First Trimester as a Risk Factor for the Development of Gestational Diabetes Mellitus. Diabetes Re-search and Clinical Practice, 142, 130-138. [Google Scholar] [CrossRef] [PubMed]
[35] Sancak, S., Aydın, H., Sargin, M., et al. (2017) The Cestational Period and It Does Not Play a Role in Development of Gestational Diabetes Mellitus. Acta Endocrinologica, 13, 393-399. [Google Scholar] [CrossRef] [PubMed]
[36] Świrska, J., Zwolak, A., DudziŃSka, M., et al. (2018) Gestational Dia-betes Mellitus—Literature Review on Selected Cytokines and Hormones of Confirmed or Possible Role in Its Pathogen-esis. Ginekologia Polska, 89, 522-527. [Google Scholar] [CrossRef] 
[37] Wu, H. and Ballantyne, C.M. (2020) Metabolic Inflammation and In-sulin Resistance in Obesity. Circulation Research, 126, 1549-1564. [Google Scholar] [CrossRef] 
[38] Stephens, J.M., Lee, J. and Pilch, P.F. (1997) Tumor Necrosis Factor-α-Induced Insulin Resistance in 3T3-L1 Adipocytes Is Accompanied by a Loss of Insulin Receptor Sub-strate-1 and GLUT4 Expression without a Loss of Insulin Receptor-Mediated Signal Transduction. Journal of Biological Chemistry, 272, 971-976. [Google Scholar] [CrossRef] [PubMed]
[39] Hotamisligil, G.S., Murray, D.L., Choy, L.N., et al. (1994) Tumor Ne-crosis Factor α Inhibits Signaling from the Insulin Receptor. Proceedings of the National Academy of Sciences of the United States of America, 91, 4854-4858. [Google Scholar] [CrossRef] [PubMed]
[40] Ramachandrayya, S.A., D’Cunha, P. and Rebeiro, C. (2020) Mater-nal Circulating Levels of Adipocytokines and Insulin Resistance as Predictors of Gestational Diabetes Mellitus: Prelimi-nary Findings of a Longitudinal Descriptive Study. Journal of Diabetes & Metabolic Disorders, 19, 1447-1452. [Google Scholar] [CrossRef] [PubMed]
[41] 卢敏, 王英, 陈青, 等. 炎性及脂肪细胞因子与妊娠期糖尿病发病的相关性及在产褥期的变化[J]. 中国妇幼保健, 2018, 33(8): 1767-1770.
[42] Alamolhoda, S.H., Yazdkhasti, M., Namdari, M., et al. (2020) Association between C-Reactive Protein and Gestational Diabetes: A Prospective Study. Journal of Obstetrics and Gynaecology, 40, 349-353. [Google Scholar] [CrossRef] [PubMed]
[43] Syngelaki, A., Visser, G.H., Krithinakis, K., et al. (2016) First Trimester Screening for Gestational Diabetes Mellitus by Maternal Factors and Markers of Inflammation. Metabo-lism, 65, 131-137. [Google Scholar] [CrossRef] [PubMed]
[44] Lainampetch, J., Panprathip, P., Phosat, C., et al. (2019) Asso-ciation of Tumor Necrosis Factor α, Interleukin 6, and C-Reactive Protein with the Risk of Developing Type 2 Diabetes: A Retrospective Cohort Study of Rural Thais. Journal of Diabetes Research, 2019, Article ID: 9051929. [Google Scholar] [CrossRef] [PubMed]
[45] Amirian, A., Mahani, M.B. and Abdi, F. (2020) Role of Interleukin-6 (IL-6) in Predicting Gestational Diabetes Mellitus. Obstetrics & Gynecology Science, 63, 407-416. [Google Scholar] [CrossRef] [PubMed]

为你推荐